A detailed history of Deutsche Bank Ag\ transactions in Astrazeneca PLC stock. As of the latest transaction made, Deutsche Bank Ag\ holds 158,585 shares of AZN stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
158,585
Previous 155,686 1.86%
Holding current value
$10.6 Million
Previous $12.1 Million 1.77%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $222,266 - $254,010
2,899 Added 1.86%
158,585 $12.4 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $23.4 Million - $28.4 Million
-350,972 Reduced 69.27%
155,686 $12.1 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $221,905 - $252,956
3,636 Added 0.72%
506,658 $34.3 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $373,568 - $418,174
6,036 Added 1.21%
503,022 $33.9 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $157,326 - $173,944
2,426 Added 0.49%
496,986 $33.7 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $1.52 Million - $1.64 Million
-21,684 Reduced 4.2%
494,560 $35.4 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $468,825 - $531,558
7,424 Added 1.46%
516,244 $35.8 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $13.2 Million - $17.1 Million
-242,863 Reduced 32.31%
508,820 $34.5 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $6.18 Million - $15.8 Million
-116,575 Reduced 13.43%
751,683 $41.2 Million
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $30.3 Million - $36.4 Million
-511,553 Reduced 37.07%
868,258 $57.4 Million
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $39.6 Million - $47.7 Million
-710,532 Reduced 33.99%
1,379,811 $91.5 Million
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $30.9 Million - $36.6 Million
572,921 Added 37.76%
2,090,343 $122 Million
Q3 2021

Nov 04, 2021

BUY
$55.56 - $60.79 $37.3 Million - $40.8 Million
671,294 Added 79.34%
1,517,422 $91.1 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $15.1 Million - $18.8 Million
312,378 Added 58.53%
846,128 $50.7 Million
Q1 2021

May 13, 2021

BUY
$47.16 - $54.44 $104,695 - $120,856
2,220 Added 0.42%
533,750 $26.5 Million
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $371,905 - $444,723
-7,665 Reduced 1.42%
531,530 $26.6 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $4.8 Million - $5.53 Million
-90,463 Reduced 14.37%
539,195 $29.5 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $36,764 - $47,179
853 Added 0.14%
629,658 $33.3 Million
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $4.27 Million - $5.81 Million
-113,118 Reduced 15.25%
628,805 $28.1 Million
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $3.11 Million - $3.7 Million
73,354 Added 10.97%
741,923 $37 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $6.83 Million - $7.75 Million
170,358 Added 34.19%
668,569 $29.8 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $42.1 Million - $47 Million
-1,128,754 Reduced 69.38%
498,211 $20.6 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $36.7 Million - $44.5 Million
1,033,385 Added 174.09%
1,626,965 $65.8 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $2.63 Million - $2.96 Million
-71,354 Reduced 10.73%
593,580 $22.5 Million
Q3 2018

Dec 21, 2021

BUY
$34.76 - $39.72 $6.22 Million - $7.11 Million
179,035 Added 36.85%
664,934 $26.3 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $7.03 Million - $8.03 Million
-202,275 Reduced 29.39%
485,899 $19.2 Million
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $7 Million - $7.51 Million
202,707 Added 41.76%
688,174 $24.2 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $2.18 Million - $2.42 Million
66,077 Added 15.76%
485,467 $17 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $875,286 - $948,659
27,276 Added 6.96%
419,390 $14.6 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $11.4 Million - $13.3 Million
392,114
392,114 $13.3 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.